Answers are grounded in this paper and cite their sources.
The in vitro activity of telavancin was tested against 743 predominantly antimicrobial-resistant, gram-positive isolates. Telavancin was highly active against methicillin-resistant staphylococci (MIC(90), 0.5 to 1 microg/ml), streptococci (all MICs, < or =0.12 microg/ml), and VanB-type enterococci (all MICs, < or =2 microg/ml). Time-kill studies demonstrated the potent bactericidal activity of telavancin.
No takes yet. Share an insight, caveat, or question.
Krause et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: